Search
01/01/2024
Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression.
Suarez R, Villarreal C, Nahuelpán Y, Jara C, Oyarzún C, Alarcón S, Díaz-Encarnación MM, Guillén-Gómez E, Quezada C, San Martín R. Defective insulin-stimulated equilibrative nucleoside transporter-2 activity and altered subcellular transporter distribution drive the loss of adenosine homeostasis in diabetic kidney disease progression.. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2024; 1870(1)DOI:10.1016/j.bbadis.2023.166890. PMID:37734469. IF:4.200(Q1/2D).
01/11/2023
Entering into 2.0 cystinuric management with a medical digital tool to monitor urine pH: a prospective, randomized study.
Angerri O, Gracia S, Rousaud F, Kanashiro A, Emiliani E. Entering into 2.0 cystinuric management with a medical digital tool to monitor urine pH: a prospective, randomized study.. Actas Urologicas Espanolas. 2023; 47(9)DOI:10.1016/j.acuroe.2023.04.004. PMID:37086842. IF:(Q/D).
01/10/2023
The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.
Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Robles NR, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Bestard O, Praga M, Fulladosa X, Soler MJ. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes.. Clinical Kidney Journal. 2023; 16(10)DOI:10.1093/ckj/sfad142. PMID:37779839. IF:(Q/D).
01/09/2023
Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study.
Bichet DG, Hopkin RJ, Aguiar P, Allam SR, Chien YH, Giugliani R, Kallish S, Kineen S, Lidove O, Niu DM, Olivotto I, Politei J, Rakoski P, Torra R, Tøndel C, Hughes DA. Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study.. Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1220637. PMID:37727761. IF:3.100(Q1/2D).
01/03/2026
Atypical Anti-Glomerular Basement Membrane Disease
Fernández-Lorente, L, Shabaka, A, Mora-Gutiérrez, JM, Caravaca-Fontán, F, Maldonado-Martin, M, Cabello, V, Marco, H, Temprado, A, Rivera, C, Facal, L, Barros, X, Manrique, J, Santos, AP, Fernández-Juárez, G, González, CC. Atypical Anti-Glomerular Basement Membrane Disease. Kidney International Reports. 2026; 11(3)DOI:10.1016/j.ekir.2025.103732. PMID:41584267. IF:5.700(Q1/1D).
01/01/2026
Consensus document on the diagnosis and treatment of acute kidney injury
Terrades, NR, Benitez, PR, Gallardo, JMU, De Valdenebro, M, Salgueira, M, Andujar, AM, Martins, J, Ramos-Gali, A, Moreno, JA, de la Cuerda, C, Lloret, MJ, Menéndez, D, Acosta-Ochoa, I, Romero-González, G, Poch, E. Consensus document on the diagnosis and treatment of acute kidney injury. NEFROLOGIA. 2026; 46(1)DOI:10.1016/j.nefro.2025.501360. PMID:. IF:2.600(Q2/4D).